Mitchel is a reporter for MDedge based in the Philadelphia area. He started with the company in 1992, when it was International Medical News Group (IMNG), and has since covered a range of medical specialties. Mitchel trained as a virologist at Roswell Park Memorial Institute in Buffalo, and then worked briefly as a researcher at Boston Children's Hospital before pivoting to journalism as a AAAS Mass Media Fellow in 1980. His first reporting job was with Science Digest magazine, and from the mid-1980s to early-1990s he was a reporter with Medical World News. @mitchelzoler
News
FDA Advisory Panel Unanimously Backs Biosimilars for Humira, Enbrel
News
FDA’s arthritis advisory committee unanimously backs biosimilar Humira
News
Statement warns of drugs causing or exacerbating heart failure
News
Statement Warns of Drugs Causing or Exacerbating Heart Failure
News
What difference would an empagliflozin CVD indication make?
News
Absorb bioresorbable vascular scaffold wins FDA approval
News
Pharma jousts statistically for an ankylosing spondylitis edge
News
FDA panel narrowly endorses empagliflozin’s cardiovascular mortality benefit
News
FDA Panel Narrowly Endorses Empagliflozin’s Cardiovascular Mortality Benefit
News
NSAID plus TNFi linked to less ankylosing spondylitis progression
News
NSAID plus TNFi linked to less ankylosing spondylitis progression
News
Primary care gout patients often discontinue allopurinol
News
Elusive evidence pervades ESC’s 2016 heart failure guidelines
News
Single rituximab dose slows rheumatoid arthritis development
Video
